MDA (UK Medical Devices Agency) warns on GEMS (General Electric Medical Systems) shock-hazard monitors:
This article was originally published in Clinica
Executive Summary
Patient monitors made by General Electric Medical Systems (GEMS) Information Technologies and Critikon are the subject of a UK Medical Devices Agency (MDA) hazard notice. The agency warns that the DINAMAP PRO 100-400 and PRO 1000 series blood pressure and vital signs monitors can pose a risk of electric shock when the mains input connector is pulled out, thereby exposing live terminals. The warning, issued on August 22 2002, does not affect models manufactured after November 15 2001. GEMS has implemented a modification programme and all units are due to be upgraded by December 2002.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.